| Date Filed | Type | Description |
| 08/22/2023 |
4
| Rosalind Advisors, Inc. (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Exercised (in-or-at-the-money) options to buy
@ $1000, valued at
$0 |
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
SC 13G
| Rosalind Advisors, Inc. reports a 6.1% stake in MEDIWOUND LTD. |
| 12/21/2022 |
SC 13D/A
| Rosalind Advisors, Inc. reports a 9.9% stake in Delcath Systems, Inc. |
| 12/16/2022 |
4
| Rosalind Advisors, Inc. (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 15,215 shares
@ $3.6178, valued at
$55k
|
|
| 12/14/2022 |
4
| Rosalind Advisors, Inc. (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 692,042 options to buy
@ $0.01, valued at
$6.9k
|
|
| 11/02/2022 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 10% stake in Cellectar Biosciences, Inc. |
| 07/21/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/06/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/21/2022 |
4
| Rosalind Advisors, Inc. (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 1,600 shares
@ $6.25, valued at
$10k
|
|
| 04/19/2022 |
4
| Rosalind Advisors, Inc. (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 2,000 shares
@ $6.3487, valued at
$12.7k
|
|
| 04/14/2022 |
4
| Rosalind Advisors, Inc. (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 1,500 shares
@ $6.45, valued at
$9.7k
|
|
| 04/12/2022 |
4
| Rosalind Advisors, Inc. (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 2,500 shares
@ $6.48, valued at
$16.2k
|
|
| 04/08/2022 |
4
| Rosalind Advisors, Inc. (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 1,000 shares
@ $6.49, valued at
$6.5k
Bought 1,000 shares
@ $6.41, valued at
$6.4k
|
|
| 03/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/09/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/14/2022 |
5
| Rosalind Advisors, Inc. (Director) has filed a Form 5 on DELCATH SYSTEMS, INC. |
| 02/14/2022 |
SC 13D/A
| Rosalind Advisors, Inc. reports a 9.9% stake in Delcath Systems, Inc. |
| 02/14/2022 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 1.5% stake in PhaseBio Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 0% stake in PLx Pharma Inc. |
| 02/11/2022 |
SC 13G
| Rosalind Advisors, Inc. reports a 5.8% stake in Galera Therapeutics, Inc. |
| 01/21/2022 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 10% stake in Cellectar Biosciences, Inc. |
| 01/20/2022 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 6.5% stake in UNICYCIVE THERAPEUTICS, INC. |
| 01/20/2022 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 8.1% stake in Myomo, Inc. |
| 01/03/2022 |
4
| Rosalind Advisors, Inc. (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 2,000 shares
@ $7.56, valued at
$15.1k
|
|
| 09/23/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/08/2021 |
SC 13G
| Rosalind Advisors, Inc. reports a 6% stake in Cellectar Biosciences, Inc. |
| 07/01/2021 |
4
| Rosalind Advisors, Inc. (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 5,500 shares
@ $12.76, valued at
$70.2k
|
|
| 07/01/2021 |
4/A
| Rosalind Advisors, Inc. (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 5,000 shares
@ $11.56, valued at
$57.8k
|
|
| 06/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/19/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/19/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|